OMIC Singular Genomics: Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik singulargenomics.com (OMIC)

The EV/Sales trend reflects market restraint, where the mark indicates the current valuation level for Singular Genomics Systems (OMIC). Optimism is fueled by the consumables sales model for G4 systems, which ensures a steady cash flow. However, high equipment support costs and competition are creating pressure. Meanwhile, Singular Genomics Systems (OMIC) is actively scaling the expansion of its high-speed genetic platforms across laboratories.

Singular Genomics Systems (OMIC): Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 19.11.2026

Singular Genomics Corp - rincian analitis lan metrik utama (OMIC)

- rega lan prakiraan konsensus rega:
Analisis wiwitan perusahaan:OMIC (Singular Genomics)
Produk asli Singular Genomics Systems Inc

The "razor and blade" model of Singular Genomics (OMIC) ensures a steady stream of recurring revenue from consumables, creating a foundation for high business margins. The current EV/Sales ratio, standing at , reflects the total enterprise value minus net debt per unit of sales, allowing investors to determine the asset's market equilibrium and promptly identify undervaluation risks in the event of a revenue decline.

Pesaing langsung

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|Phio Pharmaceuticals - Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Mustang Bio, Inc. (MBIO)|Rasio total nilai perusahaan marang pendapatan TransCode Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan Bionano Genomics BNGO|Nilai bisnis marang pendapatan APDN|BLUE - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan IPA|Omega Therapeutics, Inc. (OMGA) - Rasio nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan